IBDEI13H ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19317,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19317,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,19317,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,19317,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,19318,0)
 ;;=276.0^^105^1230^30
 ;;^UTILITY(U,$J,358.3,19318,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19318,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,19318,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,19318,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,19319,0)
 ;;=276.1^^105^1230^33
 ;;^UTILITY(U,$J,358.3,19319,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19319,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,19319,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,19319,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,19320,0)
 ;;=275.3^^105^1230^27
 ;;^UTILITY(U,$J,358.3,19320,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19320,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,19320,1,5,0)
 ;;=5^Hyper Or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,19320,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,19321,0)
 ;;=250.40^^105^1230^16
 ;;^UTILITY(U,$J,358.3,19321,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19321,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,19321,1,5,0)
 ;;=5^DM type II with Nephropathy
 ;;^UTILITY(U,$J,358.3,19321,2)
 ;;=DM type II with Nephropathy^267837^583.81
 ;;^UTILITY(U,$J,358.3,19322,0)
 ;;=790.93^^105^1230^1
 ;;^UTILITY(U,$J,358.3,19322,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19322,1,4,0)
 ;;=4^790.93
 ;;^UTILITY(U,$J,358.3,19322,1,5,0)
 ;;=5^Abnormal PSA
 ;;^UTILITY(U,$J,358.3,19322,2)
 ;;=Abnormal PSA^295772
 ;;^UTILITY(U,$J,358.3,19323,0)
 ;;=627.3^^105^1230^3
 ;;^UTILITY(U,$J,358.3,19323,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19323,1,4,0)
 ;;=4^627.3
 ;;^UTILITY(U,$J,358.3,19323,1,5,0)
 ;;=5^Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,19323,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,19324,0)
 ;;=607.1^^105^1230^6
 ;;^UTILITY(U,$J,358.3,19324,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19324,1,4,0)
 ;;=4^607.1
 ;;^UTILITY(U,$J,358.3,19324,1,5,0)
 ;;=5^Balanitis
 ;;^UTILITY(U,$J,358.3,19324,2)
 ;;=^12530
 ;;^UTILITY(U,$J,358.3,19325,0)
 ;;=596.0^^105^1230^7
 ;;^UTILITY(U,$J,358.3,19325,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19325,1,4,0)
 ;;=4^596.0
 ;;^UTILITY(U,$J,358.3,19325,1,5,0)
 ;;=5^Bladder Neck Obstruction
 ;;^UTILITY(U,$J,358.3,19325,2)
 ;;=^15144
 ;;^UTILITY(U,$J,358.3,19326,0)
 ;;=595.0^^105^1230^10
 ;;^UTILITY(U,$J,358.3,19326,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19326,1,4,0)
 ;;=4^595.0
 ;;^UTILITY(U,$J,358.3,19326,1,5,0)
 ;;=5^Cystitis, Acute
 ;;^UTILITY(U,$J,358.3,19326,2)
 ;;=^259104
 ;;^UTILITY(U,$J,358.3,19327,0)
 ;;=595.82^^105^1230^11
 ;;^UTILITY(U,$J,358.3,19327,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19327,1,4,0)
 ;;=4^595.82
 ;;^UTILITY(U,$J,358.3,19327,1,5,0)
 ;;=5^Cystitis, Radiation
 ;;^UTILITY(U,$J,358.3,19327,2)
 ;;=^270391
 ;;^UTILITY(U,$J,358.3,19328,0)
 ;;=596.59^^105^1230^17
 ;;^UTILITY(U,$J,358.3,19328,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19328,1,4,0)
 ;;=4^596.59
 ;;^UTILITY(U,$J,358.3,19328,1,5,0)
 ;;=5^Detrusor Muscle Insuff
 ;;^UTILITY(U,$J,358.3,19328,2)
 ;;=^270393
 ;;^UTILITY(U,$J,358.3,19329,0)
 ;;=788.1^^105^1230^18
 ;;^UTILITY(U,$J,358.3,19329,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19329,1,4,0)
 ;;=4^788.1
 ;;^UTILITY(U,$J,358.3,19329,1,5,0)
 ;;=5^Dysuria
 ;;^UTILITY(U,$J,358.3,19329,2)
 ;;=^37716
 ;;^UTILITY(U,$J,358.3,19330,0)
 ;;=604.90^^105^1230^41
 ;;^UTILITY(U,$J,358.3,19330,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19330,1,4,0)
 ;;=4^604.90
 ;;^UTILITY(U,$J,358.3,19330,1,5,0)
 ;;=5^Orchitis/Epididymit
 ;;
 ;;$END ROU IBDEI13H
